{"pmid":32464585,"title":"Evolution and resolution of brain involvement associated with SARS- CoV2 infection: A close Clinical - Paraclinical follow up study of a case.","text":["Evolution and resolution of brain involvement associated with SARS- CoV2 infection: A close Clinical - Paraclinical follow up study of a case.","The new severe acute respiratory syndrome- coronavirus 2 is reported to affect the nervous system. Among the reports of the various neurological manifestations, there are a few documented specific processes to explain the neurological signs. We report a para-infectious encephalitis patient with clinical, laboratory, and imaging findings during evolution and convalescence phase of coronavirus infection. This comprehensive overview can illuminate the natural history of similar cases. As the two previously reported cases of encephalitis associated with this virus were not widely discussed regarding the treatment, we share our successful approach and add some recommendations about this new and scarce entity.","Mult Scler Relat Disord","Afshar, Hale","Yassin, Zeynab","Kalantari, Saeed","Aloosh, Oldooz","Lotfi, Tayebeh","Moghaddasi, Mehdi","Sadeghipour, Alireza","Emamikhah, Maziar","32464585"],"abstract":["The new severe acute respiratory syndrome- coronavirus 2 is reported to affect the nervous system. Among the reports of the various neurological manifestations, there are a few documented specific processes to explain the neurological signs. We report a para-infectious encephalitis patient with clinical, laboratory, and imaging findings during evolution and convalescence phase of coronavirus infection. This comprehensive overview can illuminate the natural history of similar cases. As the two previously reported cases of encephalitis associated with this virus were not widely discussed regarding the treatment, we share our successful approach and add some recommendations about this new and scarce entity."],"journal":"Mult Scler Relat Disord","authors":["Afshar, Hale","Yassin, Zeynab","Kalantari, Saeed","Aloosh, Oldooz","Lotfi, Tayebeh","Moghaddasi, Mehdi","Sadeghipour, Alireza","Emamikhah, Maziar"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32464585","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.msard.2020.102216","keywords":["covid-19","sars-cov-2","encephalitis","immunotherapy","natural history","post-infectious"],"topics":["Case Report"],"weight":1,"_version_":1668079521526448128,"score":9.490897,"similar":[{"pmid":32422545,"title":"Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.","text":["Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.","BACKGROUND: Increasing research reports neurological manifestations of COVID-19 patients. SARS-CoV-2 shares homology with other human coronaviruses that have also had nervous system involvement. OBJECTIVE: To review the neurological aspects of SARS-cov2 and other coronavirus, including transmission pathways, mechanisms of invasion into the nervous system, and mechanisms of neurological disease. METHODS: We conducted a systematic review of articles in PubMed, SCOPUS and EMBASE data bases. Reviewed evidence is presented in sections of this manuscript which includes pathogenesis, neuro-invasion, encephalitis, Guillain-Barre, ADEM, multiple sclerosis, polyneuropathy, and cerebrovascular disease. RESULTS: A total 67 studies were included in the final analysis of experimental studies, case reports, series of cases, cohort studies, and systematic reviews related to neurological manifestations of SARS- CoV-2 and other human coronavirus infections. The SARS-CoV-2 receptor is expressed in the nervous system. Common reported symptoms included hyposmia, headaches, weakness, altered consciousness. Encephalitis, demyelination, neuropathy, and stroke have been associated with COVID-19. Infection through the cribriform plate and olfactory bulb and dissemination through trans-synaptic transfer are some of the mechanisms proposed. Invasion of the medullary cardiorespiratory center by SARS-CoV-2 may contribute to the refractory respiratory failure observed in critically-ill COVID-19 patients. CONCLUSION: An increasing number of reports of COVID-19 patients with neurological disorders add to emergent experimental models with neuro-invasion as a reasonable concern that SARS-CoV-2 is a new neuropathogen. How it may cause acute and chronic neurologic disorders needs to be clarified in future research.","Clin Neurol Neurosurg","Montalvan, V","Lee, J","Bueso, T","De Toledo, J","Rivas, K","32422545"],"abstract":["BACKGROUND: Increasing research reports neurological manifestations of COVID-19 patients. SARS-CoV-2 shares homology with other human coronaviruses that have also had nervous system involvement. OBJECTIVE: To review the neurological aspects of SARS-cov2 and other coronavirus, including transmission pathways, mechanisms of invasion into the nervous system, and mechanisms of neurological disease. METHODS: We conducted a systematic review of articles in PubMed, SCOPUS and EMBASE data bases. Reviewed evidence is presented in sections of this manuscript which includes pathogenesis, neuro-invasion, encephalitis, Guillain-Barre, ADEM, multiple sclerosis, polyneuropathy, and cerebrovascular disease. RESULTS: A total 67 studies were included in the final analysis of experimental studies, case reports, series of cases, cohort studies, and systematic reviews related to neurological manifestations of SARS- CoV-2 and other human coronavirus infections. The SARS-CoV-2 receptor is expressed in the nervous system. Common reported symptoms included hyposmia, headaches, weakness, altered consciousness. Encephalitis, demyelination, neuropathy, and stroke have been associated with COVID-19. Infection through the cribriform plate and olfactory bulb and dissemination through trans-synaptic transfer are some of the mechanisms proposed. Invasion of the medullary cardiorespiratory center by SARS-CoV-2 may contribute to the refractory respiratory failure observed in critically-ill COVID-19 patients. CONCLUSION: An increasing number of reports of COVID-19 patients with neurological disorders add to emergent experimental models with neuro-invasion as a reasonable concern that SARS-CoV-2 is a new neuropathogen. How it may cause acute and chronic neurologic disorders needs to be clarified in future research."],"journal":"Clin Neurol Neurosurg","authors":["Montalvan, V","Lee, J","Bueso, T","De Toledo, J","Rivas, K"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422545","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.clineuro.2020.105921","keywords":["covid-19","coronavirus","encephalitis","neurological manifestations","sars-cov-2"],"topics":["Mechanism"],"weight":1,"_version_":1667254896663986176,"score":204.00533},{"pmid":32503088,"title":"A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.","text":["A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.","BACKGROUND: We systematically reviewed available evidence for reports of neurological signs and symptoms in Coronavirus disease (COVID)-19 patients to identify cases with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection or immune-mediated reaction in the nervous system. METHODS: We followed PRISMA guidelines and used the MEDLINE, EMBASE, Google Scholar, MedRxiv and ChinaXiv databases to search for papers on COVID-19 and nervous system involvement which were published from January 1(st) to April 24(th) 2020. Data on design, sample size, neurologic assessment and related work-up were extracted. Biases were assessed with the Newcastle-Ottawa scale. RESULTS: We analysed 27 publications on potential neuroinvasive or parainfectious neurological complications of COVID-19. The reports focused on smell and taste (n=5) and evaluation of neurological symptoms and signs in cohorts (n=5). There were cases of Guillain-Barre syndrome/Miller-Fisher syndrome/cranial neuropathy (7 cases), meningitis/encephalitis (9 cases) and various other conditions (5 cases). Patients with cerebrospinal fluid (CSF) examination and in particular SARS-CoV-2 PCR was negligible. Amongst, two had a positive SARS-CoV-2 PCR exam of CSF specimen. The study of potential parenchymal involvement with magnetic resonance imaging was rare. Only 4 reports received a rating for the highest quality standards. CONCLUSION: This systematic review failed to establish comprehensive insights to nervous system manifestations of COVID-19 beyond immune-mediated complications as aftermath of respiratory symptoms. The authors therefore provide guidance for more careful clinical, diagnostic and epidemiological studies to characterize the manifestations and burden of neurological disease caused by SARS-CoV-2 on behalf of the Infectious Disease Panel of the European Academy of Neurology.","Eur J Neurol","Romoli, Michele","Jelcic, Ilijas","Bernard-Valnet, Raphael","Garcia Azorin, David","Mancinelli, Luca","Akhvlediani, Tamar","Monaco, Salvatore","Taba, Pille","Sellner, Johann","32503088"],"abstract":["BACKGROUND: We systematically reviewed available evidence for reports of neurological signs and symptoms in Coronavirus disease (COVID)-19 patients to identify cases with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection or immune-mediated reaction in the nervous system. METHODS: We followed PRISMA guidelines and used the MEDLINE, EMBASE, Google Scholar, MedRxiv and ChinaXiv databases to search for papers on COVID-19 and nervous system involvement which were published from January 1(st) to April 24(th) 2020. Data on design, sample size, neurologic assessment and related work-up were extracted. Biases were assessed with the Newcastle-Ottawa scale. RESULTS: We analysed 27 publications on potential neuroinvasive or parainfectious neurological complications of COVID-19. The reports focused on smell and taste (n=5) and evaluation of neurological symptoms and signs in cohorts (n=5). There were cases of Guillain-Barre syndrome/Miller-Fisher syndrome/cranial neuropathy (7 cases), meningitis/encephalitis (9 cases) and various other conditions (5 cases). Patients with cerebrospinal fluid (CSF) examination and in particular SARS-CoV-2 PCR was negligible. Amongst, two had a positive SARS-CoV-2 PCR exam of CSF specimen. The study of potential parenchymal involvement with magnetic resonance imaging was rare. Only 4 reports received a rating for the highest quality standards. CONCLUSION: This systematic review failed to establish comprehensive insights to nervous system manifestations of COVID-19 beyond immune-mediated complications as aftermath of respiratory symptoms. The authors therefore provide guidance for more careful clinical, diagnostic and epidemiological studies to characterize the manifestations and burden of neurological disease caused by SARS-CoV-2 on behalf of the Infectious Disease Panel of the European Academy of Neurology."],"journal":"Eur J Neurol","authors":["Romoli, Michele","Jelcic, Ilijas","Bernard-Valnet, Raphael","Garcia Azorin, David","Mancinelli, Luca","Akhvlediani, Tamar","Monaco, Salvatore","Taba, Pille","Sellner, Johann"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32503088","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/ene.14382","keywords":["covid-19","sars-cov-2","cerebrospinal fluid","encephalitis","neuroinvasion","neurological complications"],"topics":["Diagnosis"],"weight":1,"_version_":1668890966370549760,"score":196.34058},{"pmid":32479911,"title":"COVID-19-associated encephalitis mimicking glial tumor: a case report.","text":["COVID-19-associated encephalitis mimicking glial tumor: a case report.","BACKGROUND: Reports on neurologic manifestations of coronavirus disease 2019 (COVID-19) have attracted broad attention. We present the unusual case of COVID-19-associated encephalitis mimicking a glial tumor. CASE DESCRIPTION: A 35-year-old woman presented with headache and seizures. T2 fluid-attenuated inverse recovery imaging showed hyperintensities in the left temporal lobe. Magnetic resonance spectroscopy showed an elevated choline peak. Imaging findings were suggestive of high-grade glioma. Antiepileptic medication failed to achieve seizure control. Left anterior temporal lobectomy was performed. The patient had no post-operative deficits and her symptoms completely improved. Histological examination revealed encephalitis. Post-operatively, our patient was tested positive for COVID-19. CONCLUSIONS: Our case raises awareness of neurologic manifestations of the disease and their potential to mimic glial tumors. For prompt diagnosis and prevention of transmission, clinicians should consider COVID-19 in patients with similar presentation.","World Neurosurg","Efe, Ibrahim Efecan","Aydin, Orhun Utku","Alabulut, Alper","Celik, Ozgur","Aydin, Kerameddin","32479911"],"abstract":["BACKGROUND: Reports on neurologic manifestations of coronavirus disease 2019 (COVID-19) have attracted broad attention. We present the unusual case of COVID-19-associated encephalitis mimicking a glial tumor. CASE DESCRIPTION: A 35-year-old woman presented with headache and seizures. T2 fluid-attenuated inverse recovery imaging showed hyperintensities in the left temporal lobe. Magnetic resonance spectroscopy showed an elevated choline peak. Imaging findings were suggestive of high-grade glioma. Antiepileptic medication failed to achieve seizure control. Left anterior temporal lobectomy was performed. The patient had no post-operative deficits and her symptoms completely improved. Histological examination revealed encephalitis. Post-operatively, our patient was tested positive for COVID-19. CONCLUSIONS: Our case raises awareness of neurologic manifestations of the disease and their potential to mimic glial tumors. For prompt diagnosis and prevention of transmission, clinicians should consider COVID-19 in patients with similar presentation."],"journal":"World Neurosurg","authors":["Efe, Ibrahim Efecan","Aydin, Orhun Utku","Alabulut, Alper","Celik, Ozgur","Aydin, Kerameddin"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32479911","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.wneu.2020.05.194","keywords":["covid-19","sars-cov-2","coronavirus","encephalitis","spectroscopy"],"topics":["Case Report"],"weight":1,"_version_":1668437835186700288,"score":187.01155},{"pmid":32387786,"title":"Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community.","text":["Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community.","BACKGROUND: The coronavirus disease of 2019 (COVID-19) that is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently been designated a pandemic by the World Health Organization, affecting 2.7 million individuals globally as of April 25, 2020 with over 187,000 deaths. A growing body of evidence supports central nervous system (CNS) involvement. METHODS: We conducted a review of the literature for articles concerning COVID-19 pathophysiology, neurological manifestations, and neuroscience provider recommendations and guidelines. RESULTS: CNS manifestations range from vague non-focal complaints to severe neurologic impairment associated with encephalitis. It is unclear whether neurological dysfunction is due to direct viral injury or systemic disease. The virus may affect brainstem pathways that lead to indirect respiratory dysfunction in addition to direct pulmonary injury. Necessary adaptations in patient management, triage, and diagnosis are evolving in light of ongoing scientific and clinical findings. CONCLUSIONS: This review consolidates the current body of literature regarding the neurological impact of coronaviruses, discusses the reported neurologic manifestations of COVID-19, and highlights recommendations for patient management. Specific recommendations pertaining to clinical practice for neurologists and neurosurgeons are provided.","World Neurosurg","Werner, Cassidy","Scullen, Tyler","Mathkour, Mansour","Zeoli, Tyler","Beighley, Adam","Kilgore, Mitchell D","Carr, Christopher","Zweifler, Richard M","Aysenne, Aimee","Maulucci, Christopher M","Dumont, Aaron S","Bui, Cuong J","Keen, Joseph R","32387786"],"abstract":["BACKGROUND: The coronavirus disease of 2019 (COVID-19) that is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently been designated a pandemic by the World Health Organization, affecting 2.7 million individuals globally as of April 25, 2020 with over 187,000 deaths. A growing body of evidence supports central nervous system (CNS) involvement. METHODS: We conducted a review of the literature for articles concerning COVID-19 pathophysiology, neurological manifestations, and neuroscience provider recommendations and guidelines. RESULTS: CNS manifestations range from vague non-focal complaints to severe neurologic impairment associated with encephalitis. It is unclear whether neurological dysfunction is due to direct viral injury or systemic disease. The virus may affect brainstem pathways that lead to indirect respiratory dysfunction in addition to direct pulmonary injury. Necessary adaptations in patient management, triage, and diagnosis are evolving in light of ongoing scientific and clinical findings. CONCLUSIONS: This review consolidates the current body of literature regarding the neurological impact of coronaviruses, discusses the reported neurologic manifestations of COVID-19, and highlights recommendations for patient management. Specific recommendations pertaining to clinical practice for neurologists and neurosurgeons are provided."],"journal":"World Neurosurg","authors":["Werner, Cassidy","Scullen, Tyler","Mathkour, Mansour","Zeoli, Tyler","Beighley, Adam","Kilgore, Mitchell D","Carr, Christopher","Zweifler, Richard M","Aysenne, Aimee","Maulucci, Christopher M","Dumont, Aaron S","Bui, Cuong J","Keen, Joseph R"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387786","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.wneu.2020.04.222","keywords":["covid-19","encephalitis","guideline","neuroscience","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1666428892612657152,"score":184.31061},{"pmid":32487282,"title":"Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.","text":["Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.","There are few detailed investigations of neurologic complications in severe acute respiratory syndrome coronavirus 2 infection. We describe 3 patients with laboratory-confirmed coronavirus disease who development of encephalopathy and encephalitis. Neuroimaging showed nonenhancing unilateral, bilateral, and midline changes not readily attributable to vascular causes. All 3 patients had increased cerebrospinal fluid (CSF) levels of anti-S1 IgM. One patient who died also had increased levels of anti-envelope protein IgM. CSF analysis also showed markedly increased levels of interleukin (IL)-6, IL-8, and IL-10, but severe acute respiratory syndrome coronavirus 2 was not identified in any CSF sample. These changes provide evidence of CSF periinfectious/postinfectious inflammatory changes during coronavirus disease with neurologic complications.","Emerg Infect Dis","Benameur, Karima","Agarwal, Ankita","Auld, Sara C","Butters, Matthew P","Webster, Andrew S","Ozturk, Tugba","Howell, J Christina","Bassit, Leda C","Velasquez, Alvaro","Schinazi, Raymond F","Mullins, Mark E","Hu, William T","32487282"],"abstract":["There are few detailed investigations of neurologic complications in severe acute respiratory syndrome coronavirus 2 infection. We describe 3 patients with laboratory-confirmed coronavirus disease who development of encephalopathy and encephalitis. Neuroimaging showed nonenhancing unilateral, bilateral, and midline changes not readily attributable to vascular causes. All 3 patients had increased cerebrospinal fluid (CSF) levels of anti-S1 IgM. One patient who died also had increased levels of anti-envelope protein IgM. CSF analysis also showed markedly increased levels of interleukin (IL)-6, IL-8, and IL-10, but severe acute respiratory syndrome coronavirus 2 was not identified in any CSF sample. These changes provide evidence of CSF periinfectious/postinfectious inflammatory changes during coronavirus disease with neurologic complications."],"journal":"Emerg Infect Dis","authors":["Benameur, Karima","Agarwal, Ankita","Auld, Sara C","Butters, Matthew P","Webster, Andrew S","Ozturk, Tugba","Howell, J Christina","Bassit, Leda C","Velasquez, Alvaro","Schinazi, Raymond F","Mullins, Mark E","Hu, William T"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32487282","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3201/eid2609.202122","keywords":["atlanta","covid-19","csf","georgia","sars-cov-2","united states","cerebrospinal fluid","coronavirus disease","coronaviruses","cytokines","encephalitis","encephalopathy","meningitis/encephalitis","respiratory infections","serologic analysis","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["Atlanta","Georgia","USA"],"countries":["United States","Georgia"],"countries_codes":["USA|United States","GEO|Georgia"],"topics":["Case Report"],"weight":1,"_version_":1668623433713319936,"score":164.97845}]}